Immunotolerance in Endometrial Cancer and at the Maternal-fetal Interface: Immunological Profiling of the Tumor Microenvironment in Risk Stratification of Recurrence
Clinical trial NCT06250010 · UNKNOWN
Trial details
- NCT number
- NCT06250010
- Sponsor
- Regina Elena Cancer Institute
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-13
- Primary completion
- 2025-12-13
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.